RxDoctor Payments Data

Korinne Murcek, APRN

Adult Health · Lincoln, NENPI 1154585495

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.3% of the total across 210 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 55 manufacturers, the largest accounting for just 6.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,428, 3.7 times the $388 reported in 2021. Among adult health clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,164in general payments, 2019–2025

Across 210 payments — averaging $19.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$287
  • Octapharma USA, Inc.$285
  • Seagen Inc.$242
  • Daiichi Sankyo Inc.$235
  • AbbVie$200
  • Pfizer$197
  • plus $3K from 49 others

What the payments were for

  • Food & beverage$3,88493%
  • Education$2807%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,164 in reported general payments places this provider in the 90th percentile of 58 adult health providers in Nebraska.

See all adult health providers in Nebraska

Medicare billing

Part B allowed, 2024
$22,107
Medicare patients
162
Services billed
252

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban13$7,529
XareltoRivaroxaban12$7,102
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen12$187
Dexamethasone15$183
Oxycodone Hcl12$136
Prochlorperazine Maleate17$111
Gabapentin13$85
Ondansetron Hcl21$81
Tramadol Hcl16$79
Prednisone27$65

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$197$7,52913 claims
Johnson & JohnsonXarelto$287$7,10212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 58 adult health providers in Nebraska.

Other adult health in Lincoln

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →